Explore our latest report on antimicrobial resistance (AMR) in Vietnam, which provides an in-depth analysis of antibiotic use and resistance patterns from 2019 to 2022 by using the database from the Social Health Insurance (SHI) system at the country level. This study, undertaken by the Local Health System Sustainability (LHSS) project in collaboration with Vietnam Social Security (VSS), offers valuable insights into the trends of antimicrobial consumption, including data on Defined Daily Doses (DDD), cost implications, and the impact of the COVID-19 pandemic on prescribing practices.

The video captures the significant sharing of a young student with HIV who was recently treated by a community-led social enterprise (The Niem Tin Song Tien social enterprise) participating in the current social contracting pilot in Vietnam.

Clients at an HIV clinic in Vietnam are finally having their viral load tests reimbursed, thanks to some multisectoral problem-solving facilitated by LHSS. 

An estimated 170,000 people contract TB each year in Vietnam. The new e-LMIS system helps ensure a reliable drug supply for those who need treatment.

In this webinar, we share best practices and learn how these efforts have helped to improve equitable access to care for vulnerable population groups including migrants, people living with HIV, and people living with TB.

This Question-and-Answer (Q&A) document covers commonly asked questions and answers on TB exams, treatment, and reimbursement through Social Health Insurance (SHI). It provides guidance to TB treatment facilities as they integrate SHI and transition TB treatment services into SHI. The document also includes hyperlinks as additional reference sources for readers.

Thanks to a multiyear strategy supported by LHSS and predecessor USAID projects, Vietnam now funds approximately 52 percent of its HIV/AIDS program through domestic financial resources.

2022 marked Vietnam's 10-year journey to sustain its HIV response with domestic financing (2013 – 2022).  The country now stands out as a global example for sustainability and domestic resource mobilization for its HIV program.

The Vietnam government transitions funding of TB treatment to the SHI fund with support from LHSS. This transition marks a critical milestone, ensuring uninterrupted access to life-saving treatment.

LHSS features four poster presentations at 24th International AIDS Conference.

Vietnam is one of the 30 countries with the highest burden of TB and drug-resistant TB in the world, with more than 172,000 cases and 10,400 deaths from TB in Vietnam in 2020 (WHO).  On July 1, TB treatment facilities nationwide started providing TB drugs to patients through social health insurance, marking an important milestone for financial sustainability.

This report presents findings from LHSS Vietnam's international review of diagnosis-related group contracts and provides a series of evaluations and recommendations.

This rapid assessment aimed to determine which health facilities in seven high-TB burden provinces of Vietnam meet social health insurance (SHI) requirements for TB service provision and for reimbursement of TB services through the SHI scheme.

This report provides a review of international experience to draw out practical and scientific approaches for both the Ministry of Health (MOH) and Vietnam Social Security (VSS) to consider. Conclusions and recommendations are provided.

This report discusses procurement and payment considerations related to the transition of first-line TB drug procurement from the central state budget to the social health insurance fund in Vietnam.